RBC Capital analyst Brian Abrahams downgraded Regeneron (REGN) to Sector Perform from Outperform with a price target of $662, down from $943.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REGN:
- Airbnb, Zscaler downgraded: Wall Street’s top analyst calls
- Regeneron downgraded to Equal Weight from Overweight at Wells Fargo
- Wells Fargo downgrades Regeneron after ‘disappointing’ itepekimab data
- Cautious Outlook on Regeneron: Mixed Itepekimab Results and Eylea Challenges Drive Sell Rating
- Regeneron, Sanofi: AERIFY-1 Phase 3 trial of itepekimab met primary endpoint
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue